Skip to main content
Equibles

UBS Group AG

Position in JSPR — Jasper Therapeutics, Inc.

CIK 1610520 ZURICH, V8
Back to JSPR Full portfolio

Position in JSPR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$24,737
-$46,321 QoQ
Shares Held
58,759
-27.6% QoQ
Ownership
0.177%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 44 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in JSPR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. JSPR ranks #418 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in JSPR

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $24,737 58,759
2026-03-31 $71,058 81,117
2025-12-31 $231,240 126,361
2025-09-30 $93,662 39,354
2025-06-30 $2,310,326 416,275
2025-03-31 $2,298,934 534,636
2024-12-31 $3,513,054 164,315
2024-09-30 $100,012 5,317
2024-06-30 $91,980 4,052
2022-12-31 $104,096 215,521
2022-09-30 $148,352 188,026
2022-06-30 $10,690 5,539
2021-12-31 $20,033 2,552
2021-09-30 $5,530 539